AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Biopharmaceutical company Cevec Pharmaceuticals (Cologne) says it has launched Cevec Amniocyte Production Technology (CAP-T), a transient expression system for fast, serum-free, high-yield protein production. CAP-T- technology aims to meet growing demand for an integrated platform for transient production of complex biologics. The technology allows customers to proceed …